Exploring Psychedelic Substances, Phase II and Clinical Studies by Yasmin Schmid at ALPS 2023

[@FiliFili-bf9mn]

The best talk of the conference!

[@aerobique]

wow, super! what a time to be alive..

[@MessengerRising]

Have any trials been carried out using enzyme inhibitors as part of the experimental design? It's common practice for users of psychedelics to consume inhibitors like citrus compounds or caapi resin/MAO inhibitors to intensify the trip.

[@MessengerRising]

Isn't this whole talk just stating what we already know? Science is so far behind.